Zehua Li

705 total citations · 1 hit paper
17 papers, 462 citations indexed

About

Zehua Li is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Zehua Li has authored 17 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Zehua Li's work include Photoreceptor and optogenetics research (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Cardiac Valve Diseases and Treatments (2 papers). Zehua Li is often cited by papers focused on Photoreceptor and optogenetics research (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Cardiac Valve Diseases and Treatments (2 papers). Zehua Li collaborates with scholars based in China, United Kingdom and United States. Zehua Li's co-authors include Xue Wen, Tao Li, Haitao Xiao, Ruoyu Li, Bohan Zhang, Xuewen Xu, Jiapei Dai, Pingzhen Yang, Zhuo Wang and Caiwen Ou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytica Chimica Acta and Cell Reports.

In The Last Decade

Zehua Li

17 papers receiving 452 citations

Hit Papers

Signaling pathways in obe... 2022 2026 2023 2024 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zehua Li China 9 151 148 70 58 46 17 462
Qingwei Chen China 13 192 1.3× 105 0.7× 71 1.0× 38 0.7× 49 1.1× 39 478
Zhiyuan Wang China 13 145 1.0× 79 0.5× 162 2.3× 56 1.0× 51 1.1× 61 490
Mu Yang China 15 266 1.8× 101 0.7× 66 0.9× 76 1.3× 48 1.0× 36 677
Mateusz Wątroba Poland 13 226 1.5× 186 1.3× 111 1.6× 26 0.4× 39 0.8× 25 643
Agata Binienda Poland 13 236 1.6× 133 0.9× 134 1.9× 69 1.2× 27 0.6× 31 567
Deqiu Zhu China 11 140 0.9× 97 0.7× 34 0.5× 55 0.9× 30 0.7× 24 425
Lu Sun China 14 109 0.7× 122 0.8× 87 1.2× 64 1.1× 19 0.4× 64 636
Hongxia Li China 12 188 1.2× 82 0.6× 60 0.9× 34 0.6× 31 0.7× 37 626
Tong Lin China 12 159 1.1× 64 0.4× 50 0.7× 30 0.5× 60 1.3× 45 461
Huili Sun China 17 351 2.3× 133 0.9× 115 1.6× 50 0.9× 24 0.5× 38 761

Countries citing papers authored by Zehua Li

Since Specialization
Citations

This map shows the geographic impact of Zehua Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zehua Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zehua Li more than expected).

Fields of papers citing papers by Zehua Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zehua Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zehua Li. The network helps show where Zehua Li may publish in the future.

Co-authorship network of co-authors of Zehua Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zehua Li. A scholar is included among the top collaborators of Zehua Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zehua Li. Zehua Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhao, Xuefei, Linlin Jiang, Shanshan Tang, et al.. (2025). Understanding the interplay between COVID-19 and diabetes: insights for the post-pandemic era. Frontiers in Endocrinology. 16. 1599969–1599969. 3 indexed citations
2.
Li, Zehua, Qing-Yun Hao, Yuhong Zeng, et al.. (2024). Remnant cholesterol and the risk of aortic valve calcium progression: insights from the MESA study. Cardiovascular Diabetology. 23(1). 20–20. 6 indexed citations
3.
Li, Zehua, et al.. (2024). Glutathione supplementation improves fat graft survival by inhibiting ferroptosis via the SLC7A11/GPX4 axis. Stem Cell Research & Therapy. 15(1). 25–25. 9 indexed citations
4.
Hao, Qing-Yun, Yuhong Zeng, Ying Lin, et al.. (2024). Observational and genetic association of non-alcoholic fatty liver disease and calcific aortic valve disease. Frontiers in Endocrinology. 15. 1421642–1421642. 3 indexed citations
5.
Wen, Xue, Haitao Xiao, Zehua Li, et al.. (2023). Bisphenol S induces brown adipose tissue whitening and aggravates diet-induced obesity in an estrogen-dependent manner. Cell Reports. 42(12). 113504–113504. 19 indexed citations
6.
Yan, Jing, Zehua Li, Chaobo Yang, et al.. (2023). Fucoxanthin alleviated myocardial ischemia and reperfusion injury through inhibition of ferroptosis via the NRF2 signaling pathway. Food & Function. 14(22). 10052–10068. 38 indexed citations
7.
Li, Zehua, et al.. (2023). Efficacy and safety of bridging therapy and direct mechanical thrombectomy in large vessel occlusions: a meta-analysis. Chinese Medical Journal. 136(17). 2119–2121. 1 indexed citations
8.
Wen, Xue, Man Zhu, Zehua Li, Tao Li, & Xuewen Xu. (2022). Dual effects of bisphenol A on wound healing, involvement of estrogen receptor β. Ecotoxicology and Environmental Safety. 231. 113207–113207. 14 indexed citations
9.
Li, Zehua, et al.. (2022). One-click investigation of shape influence of silver nanostructures on SERS performance for sensitive detection of COVID-19. Analytica Chimica Acta. 1234. 340523–340523. 14 indexed citations
10.
Wen, Xue, Bohan Zhang, Haitao Xiao, et al.. (2022). Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy. 7(1). 298–298. 251 indexed citations breakdown →
11.
Li, Zehua, et al.. (2021). Rehabilitative management of pelvic fractures needs to be further optimized. European Journal of Translational Myology. 31(4). 1 indexed citations
12.
Zhan, Jie, Hekai Li, Guanghui Xu, et al.. (2021). Dual-ligand supramolecular nanofibers inspired by the renin-angiotensin system for the targeting and synergistic therapy of myocardial infarction. Theranostics. 11(8). 3725–3741. 19 indexed citations
13.
Chen, Xiaoxuan, et al.. (2021). Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values. Pathology - Research and Practice. 228. 153654–153654. 3 indexed citations
14.
Liu, Hailin, Xiuli Zhang, Xinglong Zhong, et al.. (2019). Puerarin inhibits vascular calcification of uremic rats. European Journal of Pharmacology. 855. 235–243. 33 indexed citations
15.
Li, Zehua & Jiapei Dai. (2016). Biophotons Contribute to Retinal Dark Noise. Neuroscience Bulletin. 32(3). 246–252. 6 indexed citations
16.
Wang, Zhuo, et al.. (2016). Human high intelligence is involved in spectral redshift of biophotonic activities in the brain. Proceedings of the National Academy of Sciences. 113(31). 8753–8758. 41 indexed citations
17.
Li, Zehua. (2009). Variable bandwidth and one step local M-estimation of varying coefficient models. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026